| Full text | |
| Author(s): |
Napimoga, Marcelo Henrique
[1]
;
Dias Demasi, Ana Paula
[2]
;
Bossonaro, Jeruza P.
[2]
;
de Araujo, Vera Cavalcanti
[2]
;
Clemente-Napimoga, Juliana Trindade
[3]
;
Martinez, Elizabeth Ferreira
[2]
Total Authors: 6
|
| Affiliation: | [1] Sao Leopoldo Mandic Inst & Res Ctr, Lab Immunol & Mol Biol, BR-13045755 Campinas, SP - Brazil
[2] Sao Leopoldo Mandic Inst & Res Ctr, Lab Oral Pathol, BR-13045755 Campinas, SP - Brazil
[3] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol, Lab Orofacial Pain, Campinas, SP - Brazil
Total Affiliations: 3
|
| Document type: | Journal article |
| Source: | International Immunopharmacology; v. 16, n. 2, p. 131-138, JUN 2013. |
| Web of Science Citations: | 5 |
| Abstract | |
Peroxisome proliferator-activated receptor-gamma (PPAR gamma) regulates both glucose metabolism and bone mass. Evidence suggests that the therapeutic modulation of PPAR gamma with synthetic agonists activity may elicit undesirable effects on bone. However, there is no information regarding its natural agonist 15d-PGJ(2), besides its excellent anti-inflammatory action. In the present study the effects of 15d-PGJ(2) on osteoblastic cells were determined. Osteoblastic cells (MC3T3) were cultured in an osteogenic medium in the presence of 1, 3 or 10 mu M of 15d-PGJ(2) during 21 days and alizarin and Von Kossa staining were employed. The protein expression (type-I collagen, osteonectin, osteopontin, RANKL, osteoprotegerin, HDAC-9c and PPAR-gamma) was evaluated after 3 days in the presence of 15d-PGJ(2) by western blotting and indirect immunofluorescence methods. The production of mineralized extracellular matrix was observed by transmission electron microscopy. After 72 h of culture, the mRNA was extracted for RT-qPCR analysis of RUNX expression. In the presence of all 3 tested 15d-PGJ2 doses, alizarin red and Von kossa staining were positive demonstrating the ability to the osteoblast differentiation. Type-I collagen and osteonectin proteins expression were up-regulated (p < 0.05) after 72 h in the presence of the smaller doses of 15d-PGJ(2). In contrast osteopontin, RANKL and OPG expression did not significantly alter. In the presence of 15d-PGJ(2) it was possible to visualize mineralized nodules in the extracellular matrix confirmed with the increased RUNX mRNA expression. 15d-PGJ(2) at small doses increased the osteoblast activity and the bone-related proteins expression. (c) 2013 Elsevier B.V. All rights reserved. (AU) | |
| FAPESP's process: | 10/15014-9 - Evaluation of the effect of 15d-PGJ2-loaded on polymeric biodegradable nanoparticles to control the evolution of the experimental periodontal disease |
| Grantee: | Marcelo Henrique Napimoga |
| Support Opportunities: | Regular Research Grants |